RxDoctor Payments Data

Raymond Gilbert, MD

Family Medicine · Watkinsville, GANPI 1831184209

Payments from drug & device makers

$8,553in general payments, 2019–2025

Across 561 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$981
  • Amgen$781
  • AbbVie$737
  • Boehringer Ingelheim$592
  • Bayer$387
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$8,546100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,553 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$235,024
Medicare patients
541
Services billed
7,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin135$165,518
OzempicSemaglutide108$140,938
EliquisApixaban96$98,818
XareltoRivaroxaban95$96,028
RybelsusSemaglutide43$87,897
Enbrel SureclickEtanercept11$80,227
OtezlaApremilast13$79,457
Soliqua 100-33Insulin Glargine/Lixisenatide62$73,948
MounjaroTirzepatide55$56,134
TrulicityDulaglutide39$55,502
MyrbetriqMirabegron65$54,645
Dupixent SyringeDupilumab13$48,453
Tresiba Flextouch U-200Insulin Degludec49$45,972
Repatha SureclickEvolocumab42$41,372
FarxigaDapagliflozin Propanediol31$38,149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,831$228,835151 claims
Boehringer IngelheimJardiance$592$165,518135 claims
Lilly USA, LLCMounjaro, Trulicity$229$111,63694 claims
PfizerEliquis$345$98,81896 claims
Johnson & JohnsonXarelto$154$96,02895 claims
AmgenOtezla$781$79,45713 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$231$73,94862 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$981$66,129117 claims
Astellas Pharma US IncMyrbetriq$139$54,64565 claims
GSKTrelegy Ellipta, Shingrix, Arexvy, Arnuity Ellipta$262$36,714100 claims
AbbVieLinzess, Ubrelvy, Synthroid$737$33,09588 claims
MerckBelsomra, Januvia, Janumet$45$31,51046 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Watkinsville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →